Soleno Therapeutics (SLNO) News Today $56.60 +0.02 (+0.04%) Closing price 03:59 PM EasternExtended Trading$56.88 +0.28 (+0.50%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 23 at 10:00 AM | prnewswire.comAssenagon Asset Management S.A. Lowers Position in Soleno Therapeutics, Inc. $SLNOSeptember 23 at 3:39 AM | marketbeat.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 22 at 8:00 AM | prnewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by AnalystsSeptember 22 at 2:44 AM | marketbeat.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 20 at 12:36 PM | globenewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Short Interest Up 20.1% in AugustSeptember 20 at 2:40 AM | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Short Interest UpdateSeptember 19, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 9.5% - Still a Buy?September 19, 2025 | marketbeat.comSOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the FirmSeptember 18, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens BermanSeptember 18, 2025 | globenewswire.comSoleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR ExpandsSeptember 18, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 18, 2025 | prnewswire.comSoleno Therapeutics: Patient Death Unrelated To Vykat, But Safety Concerns May Undermine LaunchSeptember 17, 2025 | seekingalpha.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 17, 2025 | globenewswire.comWhat is Lifesci Capital's Estimate for SLNO Q3 Earnings?September 14, 2025 | marketbeat.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.- SLNOSeptember 13, 2025 | prnewswire.comSoleno Therapeutics (NASDAQ:SLNO) Upgraded to Strong-Buy at Lifesci CapitalSeptember 13, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Down 8.9% - What's Next?September 12, 2025 | marketbeat.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 12, 2025 | prnewswire.comOptimize Financial Inc Makes New Investment in Soleno Therapeutics, Inc. $SLNOSeptember 12, 2025 | marketbeat.comWoodline Partners LP Grows Stock Position in Soleno Therapeutics, Inc. $SLNOSeptember 12, 2025 | marketbeat.comFred Alger Management LLC Has $2.89 Million Holdings in Soleno Therapeutics, Inc. $SLNOSeptember 12, 2025 | marketbeat.comSOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the FirmSeptember 11, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens BermanSeptember 11, 2025 | globenewswire.comAre Legal Probes Shaping Trust in Soleno Therapeutics’ (SLNO) Drug Pipeline and Investor Relations?September 11, 2025 | finance.yahoo.comSoleno Therapeutics (SLNO) Falls Hard on Patient DeathSeptember 11, 2025 | msn.comSoleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs MuraSeptember 10, 2025 | businesswire.comSLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law FirmSeptember 10, 2025 | businesswire.comSoleno Therapeutics stock falls after patient death reportSeptember 10, 2025 | in.investing.comUnpacking the Latest Options Trading Trends in Soleno TherapeuticsSeptember 10, 2025 | benzinga.comSoleno drops on death of patient treated with Vykat XRSeptember 10, 2025 | msn.comSoleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details InsideSeptember 10, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 10, 2025 | globenewswire.comSoleno reports death of patient who took genetic disorder treatment, shares fallSeptember 10, 2025 | reuters.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 10, 2025 | globenewswire.comA Look at Soleno Therapeutics’s Valuation Following Legal Probes Into VYKAT XR Safety and Business PracticesSeptember 10, 2025 | finance.yahoo.comScientech Research LLC Buys 6,351 Shares of Soleno Therapeutics, Inc. $SLNOSeptember 10, 2025 | marketbeat.comHere’s Why Analysts are Bullish on Soleno Therapeutics (SLNO)September 10, 2025 | finance.yahoo.com16,899 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Trexquant Investment LPSeptember 9, 2025 | marketbeat.comSOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the FirmSeptember 8, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 8, 2025 | prnewswire.comSoleno Therapeutics, Inc. $SLNO Stake Lessened by Samlyn Capital LLCSeptember 8, 2025 | marketbeat.comGranahan Investment Management LLC Buys New Shares in Soleno Therapeutics, Inc. $SLNOSeptember 8, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 6, 2025 | globenewswire.comCheckpoint Capital L.P. Has $12.35 Million Stock Holdings in Soleno Therapeutics, Inc. $SLNOSeptember 6, 2025 | marketbeat.comAlyeska Investment Group L.P. Has $37.81 Million Stock Position in Soleno Therapeutics, Inc. $SLNOSeptember 6, 2025 | marketbeat.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 5, 2025 | prnewswire.comAllostery Investments LP Invests $1.43 Million in Soleno Therapeutics, Inc. $SLNOSeptember 5, 2025 | marketbeat.comAlly Bridge Group NY LLC Grows Position in Soleno Therapeutics, Inc. $SLNOSeptember 5, 2025 | marketbeat.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.530.71▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼138▲SLNO Articles Average Week Get the Latest News and Ratings for SLNO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Femasys News Immunovant News Penumbra News Stevanato Group News iRhythm Technologies News Bausch + Lomb News Glaukos News TransMedics Group News Envista News LivaNova News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLNO Stock Alerts